Eli Lilly on Friday said it will spend more than $3.5 billion to build a manufacturing plant in Pennsylvania’s Lehigh Valley that will help make its next-generation obesity drugs.
据CNBC 报道，周五，制药巨头美国礼来公司表示，将投资超过35亿美元（约243.3亿元）在宾夕法尼亚州利哈伊谷建造一座生产下一代减肥药的制造工厂。
That includes a closely watched experimental drug called retatrutide, which has shown the highest weight loss seen to date for any treatment in a late-stage trial.
其中，就包括备受关注的实验药物瑞他鲁肽，该药物后期试验显示出的减肥效果为迄今为止所有疗法中的最高。
It is the fourth facility in a string of new planned U.S. investments by the pharmaceutical giant. Lilly announced in February 2025 that it would spend at least $27 billion to build new domestic manufacturing facilities, adding to $23 billion in previous investments since 2020.
这将是该巨头近期宣布计划在美国进行的一系列投资中规划的第四个生产基地。2025年2月，礼来宣布将投资至少270亿美元在国内新建生产设施。此前，自2020年以来，该公司已累计投资230亿美元。
On Thursday, President Donald Trump said Lilly CEO Dave Ricks has told him the drugmaker aims to build six plants in the U.S. But Lilly has not confirmed those plans.
周四，美国总统特朗普称，礼来CEO戴夫•里克斯曾告诉他，该公司的目标是在美国建造六座工厂。不过，礼来尚未证实这些计划。
The company on Friday said it expects construction of the Pennsylvania plant to start this year and for the site to be operational in 2031.
周五，礼来表示，预计宾夕法尼亚工厂将于今年开工建设，将于2031年投入运营。
That added production capacity for upcoming weight loss treatments is crucial. Retatrutide is viewed as a key pillar of Lilly’s long-term obesity strategy after its popular injection Zepbound and upcoming obesity pill.
增加产能，对于即将推出的减肥疗法至关重要。继广受欢迎的注射剂Zepbound和即将上市的减肥药之后，瑞他鲁肽被视为礼来长期减肥战略的关键支柱。
Some health experts say retatrutide, which works by targeting three gut hormones rather than one or two, can reach patients with severe obesity who would benefit from even more weight loss than what existing injections can offer. Lilly plans to release data from seven other Phase 3 trials on the drug this year.
一些健康专家表示，瑞他鲁肽通过靶向三种肠道激素而非一两种发挥作用，能够帮助那些需要比现有注射剂更大幅度减重的重度肥胖患者。礼来公司计划今年公布该药物其他七项三期临床试验的数据。
Eli Lilly said the Pennsylvania site will bring 850 jobs to the area, including engineers, scientists, operations personnel and lab technicians, as well as 2,000 construction jobs.
礼来表示，这家新工厂将为当地带来包括工程师、科学家、运营人员和实验室技术人员在内的850个就业岗位，以及2000个建筑岗位。
